Publication | Closed Access

Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

InflammationChronic Inflammatory DiseasesAnti-inflammatoryGastrointestinal PharmacologyMedicineImmunologyGastroenterologyBirb 796Placebo-controlled TrialPharmacologyInflammatory DiseaseDigestive System Diseases